NCT05492734View on ClinicalTrials.gov

A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

August 19, 2022

Study Completion Date

August 19, 2022

Conditions
Muscular Dystrophies
Interventions
DRUG

EDG-5506

single oral dose

Trial Locations (1)

68502

Celerion, Inc., Lincoln

Sponsors
All Listed Sponsors
lead

Edgewise Therapeutics, Inc.

INDUSTRY